Is there a generic for Rescinnamine?

Yes. The FDA Orange Book lists 1 approved generic (ANDA) application for Rescinnamine, referencing the brand MODERIL. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Rescinnamine?

MODERIL (NDA 010686, PFIZER) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Rescinnamine are approved?

Rescinnamine is approved in the following dosage forms: capsule, tablet.

FDA Orange Book · active-ingredient family

Rescinnamine

Rescinnamine is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:MODERIL · NDA 010686

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · capsule, tablet

Product	Applicant	Application	TE	Approved
MODERIL×2	PFIZER	NDA 010686	—	Approved Prior to Jan 1, 1982

Generic (ANDA) products (1)

Product	Applicant	Application	TE	Approved
CINNASIL	PANRAY	ANDA 084736	—	Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Rescinnamine — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo